Transcranial direct current stimulation for major depression: a general system for quantifying transcranial electrotherapy dosage.
There has been a recent resurgence of interest in therapeutic modalities using transcranial weak electrical stimulation through scalp electrodes, such as trans-cranial direct current stimulation (tDCS), as a means of experimentally modifying and studying brain function and possibly treating psychiatric conditions. A range of electrotherapy paradigms have been investigated, but no consistent method has been indicated for reporting reproducible stimulation "dosage." Anecdotal reports, case studies, and limited clinical trials with small numbers suggest that tDCS may be effective in treating some patients with depression, but methods for selecting the optimal stimulation parameters ("dosage") are not clear, and there is no conclusive indication that tDCS is an effective treatment for depression. Larger, controlled studies are necessary to determine its safety and efficacy in a clinical setting. If tDCS can be established as an effective treatment for depression, it would represent a particularly attractive electrotherapy option, as it is a relatively benign and affordable treatment modality. An accurate system for describing reproducible treatment parameters is essential so that further studies can yield evidence-based guidelines for the clinical use of transcranial current stimulation. Development of appropriate parameters requires a biophysical understanding of how electrotherapy affects brain function and should include different paradigms for different clinical applications. As with any dosage guidelines, such a system does not supersede physician judgment on safety.
Bikson
Marom
M
Teodor T. Postolache, MD Mood and Anxiety Program, University of Maryland School of Medicine, 685 West Baltimore, MSTF Suite 930, Baltimore, MD 21201, USA. Tpostola@psych.umaryland.edu.
Bulow
Peter
P
Stiller
John W
JW
Datta
Abhishek
A
Battaglia
Fortunato
F
Karnup
Sergei V
SV
Postolache
Teodor T
TT
Br J Psychiatry. 1970 Apr;116(533):433-4
4909797
Biol Psychiatry. 2007 Dec 1;62(11):1208-16
17573044
Clin Neurophysiol. 2003 Nov;114(11):2220-2; author reply 2222-3
14580622
Bipolar Disord. 2006 Apr;8(2):203-4
16542193
Br J Psychiatry. 1964 Nov;110:773-85
14211694
Biol Psychiatry. 2005 Sep 1;58(5):347-54
16139580
Br J Psychiatry. 1968 Feb;114(507):225-32
5644387
J Neurosurg. 2004 Oct;101(4):682-6
15481726
Clin Neurophysiol. 2007 May;118(5):1166-70
17329167
J Physiol. 2000 Sep 15;527 Pt 3:633-9
10990547
Br J Psychiatry. 1964 Nov;110:768-72
14211693
Clin Neurophysiol. 2006 Jul;117(7):1623-9
16762592
Neurology. 2001 Nov 27;57(10):1899-901
11723286
J Physiol. 2004 May 15;557(Pt 1):175-90
14978199
J Neurosci Methods. 2005 Feb 15;141(2):171-98
15661300
Ir J Med Sci. 1969 Mar;8(3):133-5
5799726
Br J Psychiatry. 1974 Oct;125(0):414-5
4609533
Clin Neurophysiol. 2003 Apr;114(4):600-4
12686268
Int J Neuropsychopharmacol. 2008 Mar;11(2):249-54
17559710
Arch Gen Psychiatry. 2000 Jun;57(6):581-90
10839336
N Engl J Med. 2007 Nov 8;357(19):1939-45
17989386
Br J Psychiatry. 1964 Nov;110:786-99
14211695
Neurology. 2005 Mar 8;64(5):872-5
15753425
Conf Proc IEEE Eng Med Biol Soc. 2006;2006:1616-9
17946911
J Neural Eng. 2008 Jun;5(2):163-74
18441418
Arch Gen Psychiatry. 2000 May;57(5):425-34
10807482
IEEE Trans Biomed Eng. 1990 Oct;37(10):996-1001
2249872
Anesth Analg. 1968 Nov-Dec;47(6):717-23
4972743
Neuropsychopharmacology. 2006 Nov;31(11):2384-93
16855529